Form 468 Sample Clauses

The 'Form 468' clause designates the use of a specific standardized form, typically required for compliance, reporting, or documentation purposes within a contract or regulatory framework. In practice, this clause obligates one or both parties to complete and submit Form 468 at certain stages, such as upon the occurrence of a triggering event or as part of routine filings. By mandating the use of this form, the clause ensures consistency in information collection and helps streamline administrative processes, thereby reducing the risk of errors or omissions in required documentation.
Form 468. Within 45 days after the end of each fiscal year and at such other times as TeleSoft or Chase, may reasonably request, the Company shall deliver to TeleSoft or Chase, as the case may be, a written assessment, in form and substance reasonably satisfactory to them in order to permit them to file SBA Form 468, of the economic impact of their financing specifying the full-time equivalent jobs created or retained in connection with such investment and the impact of the financing on the Company's business in term of profits and on taxes paid by the Company and the employees. Upon request, the Company promptly (and in any event within 20 days of such request) will furnish to TeleSoft and Chase all information reasonably requested by them in order for them to comply with the requirements of 13 C.F.R. Section 107.620 or to prepare and file SBA Form 468 and any other information requested or required by the SBA or any other similar governmental agency asserting jurisdiction over such investor. The Company shall afford to representatives of the SBA reasonable access to the books, records, and properties of the Company and its subsidiaries in accordance with 13 C.F.R. Section 107.620(c). Any submission of any financial information under this paragraph shall include a certificate of the Company's president, chief executive officer, treasurer or chief financial officer.
View Source

Related to Form 468

  • Securities Exchange Commission Certification The Corporation confirms that as at the date hereof it does not have a class of securities registered pursuant to Section 12 of the U.S. Exchange Act or a reporting obligation pursuant to Section 15(d) of the U.S.

  • Short-Form Warning The Settling Entity may, but is not required to, use the following short-form warning as set forth in this subsection 2.3(b) (Short-Form Warning) or any substantially similar language so long as it is consistent with the implementing regulations, and subject to the additional requirements in subsections 2.5 and 2.6, as follows:

  • Form 15 Filing Prior to January 30 of the first year in which the Depositor is able to do so under applicable law, the Depositor shall file a Form 15 relating to the automatic suspension of reporting in respect of the Trust Fund under the Exchange Act.

  • IRS IRS shall mean the Internal Revenue Service.

  • How to File an Appeal of a Prescription Drug Denial For denials of a prescription drug claim based on our determination that the service was not medically necessary or appropriate, or that the service was experimental or investigational, you may request an appeal without first submitting a request for reconsideration. You or your physician may file a written or verbal prescription drug appeal with our pharmacy benefits manager (PBM). The prescription drug appeal must be submitted to us within one hundred and eighty (180) calendar days of the initial determination letter. You will receive written notification of our determination within thirty (30) calendar days from the receipt of your appeal. Your appeal may require immediate action if a delay in treatment could seriously jeopardize your health or your ability to regain maximum function, or would cause you severe pain. To request an expedited appeal of a denial related to services that have not yet been rendered (a preauthorization review) or for on-going services (a concurrent review), you or your healthcare provider should call: • our Grievance and Appeals Unit; or • our pharmacy benefits manager for a prescription drug appeal. Please see Section 9 for contact information. You will be notified of our decision no later than seventy-two (72) hours after our receipt of the request. You may not request an expedited review of covered healthcare services already received.